Staphylococcus aureus is a major healthcare concern due to its ability to inflict life-
threatening infections and evolve antibiotic resistance at an alarming pace. It is frequently …

The pathogen Staphylococcus aureus is recognized as one of the most frequent causes of
biofilm-associated infections. The recently identified phenol-soluble modulin (PSM) peptides …

Staphylococcus aureus (SA) is a gram-positive coccus and an opportunistic pathogen of
humans. The ability of SA to form biofilms is an important virulence mechanism because …

The presence of biofilms can negatively affect several different areas, such as the food
industry, environment, and biomedical sectors. Conditions under which bacteria grow and …

Staphylococcus aureus enhances neutrophil extracellular vesicle (EV) production. To
investigate whether S. aureus viability influences EV biogenesis, EVs were isolated from …

The high-glucose-induced cytotoxicity in diabetes has been widely recognized.
Staphylococcus aureus is the most frequent pathogen isolated from diabetic foot ulcers, but …

The present study evaluated the quebrachitol (QBC) antibiofilm and antivirulence potential
against methicillin-resistant Staphylococcus aureus (MRSA). QBC inhibited MRSA biofilm …

Haemophilus parasuis (H. parasuis) is a conditional pathogen with the ability to form
biofilms which can lead to ineffective drug treatment and severe chronic infections resulting …

Antimicrobial peptides (AMPs) are promising candidates as new anti-biofilm agents to cope
with biofilm-related infections. To date, numerous studies have evaluated the efficacy of …

Antimicrobial resistance has emerged as a serious threat to public health. Bacterial biofilm,
as a natural lifestyle, is a major contributor to resistance to antimicrobials. Azalomycin F5a, a …